ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Fortress Biotech Inc

Fortress Biotech Inc (FBIO)

2.23
0.11
(5.19%)
Al cierre: 03 Enero 3:00PM
2.23
0.00
( 0.00% )
Fuera de horario: 3:40PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
2.23
Postura de Compra
2.09
Postura de Venta
2.23
Volume Operado de la Acción
388,515
2.09 Rango del Día 2.2494
1.355 Rango de 52 semanas 2.89
Capitalización de Mercado [m]
Precio Anterior
2.12
Precio de Apertura
2.14
Última hora de negociación
15:37:02
Volumen financiero
US$ 843,336
Precio Promedio Ponderado
2.1707
Volumen promedio (3 m)
637,176
Acciones en circulación
27,604,934
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.89
Beneficio por acción (BPA)
-2.49
turnover
84.51M
Beneficio neto
-68.67M

Acerca de Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the g... Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Dover, Delaware, USA
Fundado
-
Fortress Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FBIO. The last closing price for Fortress Biotech was US$2.12. Over the last year, Fortress Biotech shares have traded in a share price range of US$ 1.355 to US$ 2.89.

Fortress Biotech currently has 27,604,934 shares in issue. The market capitalisation of Fortress Biotech is US$58.52 million. Fortress Biotech has a price to earnings ratio (PE ratio) of -0.89.

FBIO Últimas noticias

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or...

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of...

Mustang Bio Receives Positive Listing Determination from Nasdaq

WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblastoma in ongoing Phase 1 clinical trial Preclinical data support a novel combination of MB-108 (HSV-1...

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling...

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) versus Oral Doxycycline 40 mg Capsules (Oracea®) in Healthy...

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.146.69856459332.092.361.89111334772.21563195CS
40.157.211538461542.082.361.77145662.05129245CS
120.6541.13924050631.582.361.416371761.9259165CS
260.5431.95266272191.692.891.3555314641.84298222CS
52-0.49-18.01470588242.722.891.3554181621.88870101CS
156-34.97-94.005376344137.241.71.245009928.8913925CS
260-37.67-94.411027568939.991.51.2466553733.32373272CS

FBIO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Fortress Biotech?
El precio actual de las acciones de Fortress Biotech es US$ 2.23
¿Cuántas acciones de Fortress Biotech están en circulación?
Fortress Biotech tiene 27,604,934 acciones en circulación
¿Cuál es la capitalización de mercado de Fortress Biotech?
La capitalización de mercado de Fortress Biotech es USD 58.52M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Fortress Biotech?
Fortress Biotech ha negociado en un rango de US$ 1.355 a US$ 2.89 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Fortress Biotech?
El ratio precio/beneficio de Fortress Biotech es -0.89
¿Cuál es el ratio de efectivo a ventas de Fortress Biotech?
El ratio de efectivo a ventas de Fortress Biotech es 0.72
¿Cuál es la moneda de reporte de Fortress Biotech?
Fortress Biotech presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Fortress Biotech?
El último ingresos anual de Fortress Biotech es USD 84.51M
¿Cuál es el último beneficio anual de Fortress Biotech?
El último beneficio anual de Fortress Biotech es USD -68.67M
¿Cuál es la dirección registrada de Fortress Biotech?
La dirección registrada de Fortress Biotech es 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
¿Cuál es la dirección del sitio web de Fortress Biotech?
La dirección del sitio web de Fortress Biotech es www.fortressbiotech.com
¿En qué sector industrial opera Fortress Biotech?
Fortress Biotech opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MEGLMagic Empire Global Limited
US$ 0.79
(40.54%)
2.42M
PTLEPTL Ltd
US$ 10.30
(39.38%)
97.09k
PWMPrestige Wealth Inc
US$ 1.58
(36.21%)
187.85k
MBOTMicrobot Medical Inc
US$ 2.60
(21.50%)
3.09M
KITTNauticus Robotics Inc
US$ 4.59
(20.79%)
4.06M
ACONAclarion Inc
US$ 0.2001
(-32.94%)
5.61M
RAINRain Enhancement Technologies Holdco Inc
US$ 4.97
(-14.90%)
9.52k
MMVMultiMetaVerse Holdings Ltd
US$ 0.90
(-14.69%)
3.25k
CVKDCadrenal Therapeutics Inc
US$ 13.5364
(-14.60%)
7.18k
QSIQuantum Si Inc
US$ 3.9101
(-8.86%)
7.07M
QSIQuantum Si Inc
US$ 3.9101
(-8.86%)
7.07M
VEEETwin Vee PowerCats Company
US$ 0.5602
(13.63%)
5.72M
ACONAclarion Inc
US$ 0.2001
(-32.94%)
5.61M
TGLTreasure Global Inc
US$ 0.4025
(3.21%)
5.32M
NVDANVIDIA Corporation
US$ 144.53
(0.04%)
4.5M

FBIO Discussion

Ver más
rbl100 rbl100 5 días hace
You were right.

It was approved on 12/13/24.
👍️0
rbl100 rbl100 1 semana hace
Mr. Market (shorts) got their azz kicked LOL. Drug was approved by the FDA. Verify what I am saying. Go ahead. Here is the link to save you time:

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-cosibelimab-ipdl-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma

and this link in case you don't believe me:

https://www.aacr.org/patients-caregivers/progress-against-cancer/first-approval-for-a-new-immune-checkpoint-inhibitor/
👍️0
rbl100 rbl100 1 semana hace
It was approved.
👍️0
rbl100 rbl100 1 semana hace
Just found out FDA approved the cancer drug on the 13th. No one else knows. Just a tip for you. It was all done in secret I suppose.
👍️0
rbl100 rbl100 1 semana hace
FDA APPROVES FBIO cancer drug !!!!

FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma

On December 13, 2024, the Food and Drug Administration approved cosibelimab-ipdl (Unloxcyt, Checkpoint Therapeutics, Inc.), a programmed death ligand-1 (PD-L1) blocking antibody, for adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.

Full prescribing information for Unloxcyt will be posted on Drugs@FDA.
👍️0
rbl100 rbl100 1 semana hace
CKPT stake which is a partner of FBIO got approval and is a good thing. It took Apple 15 years to blow up in price. Holding what I have....
👍️0
Paullee Paullee 4 semanas hace
Mr Market is not saying that
👍️0
Monksdream Monksdream 4 semanas hace
Confusing. Call the company
👍️0
rbl100 rbl100 4 semanas hace
Did the FDA already tell FBIO that they rejected their filing? Someone on the CVM board says they did. That the FDA told the company executives that they are NOT getting approval. Is this true? How is this lawful? They were supposed to be getting the answer in a couple weeks.
👍️0
chumfm chumfm 1 mes hace
Always a good sign when you see insider buying.Threw DERM, FBIO has learned exactly what the FDA is looking for.This will be the time the stock gets the recognition it deserves.Good luck and good trading.
👍️ 1
StocktonCA StocktonCA 1 mes hace
Institutions holding Fortress Biotech
Vanguard and Blackrock both own shares and many others

 

Get Institutions for : 



Fortress Biotech, Inc. (FBIO)   $0.29 0.00 (0.00%) as of 4:30 Mon 10/9

?
Download

      Institutional Holders
Viewing Quarter :    Total Institutions: ? 49   ? 0

?

?

Total shares held : 

4,073,262  

% of shares held : 

4.35%  Changes In: ?

?

?

New/increased positions vs   

old/decreased positions : 

?  10  

Amount of shares held : 

724,444  

% of shares held change : 

?  0.77%  Quarter Price vs. Current Price: ?

?

?

Last Quarter's Starting Price : 

N/A  

Last Quarter's Ending Price : 

N/A  

Last Quarter's Average Price : 

N/A  

Change from last quarter's     

avg. price to the last closing  : 

(%)  

?

?   ?
All Securities Held :

Positions

     Shares

% Of
Total Shares

New Positions :

4

 146,601

 3.6%

  Increased Positions :

21

 993,803

 24.4%

  Unchanged Positions :

13

 460,712

 11.31%

  Decreased Positions :

11

-345,374

-8.48%

  Closed Positions :

4

-70,586

-1.73%

  Guru Positions :

0

 0%

  ?

  Page 1 of 1  

Free Registration Required For Full Results





            Institution NamePortfolio
PositionNew/Closed
Position
Filing Date
Total Shares
Total Value
Change in Shares
File? ?  VANGUARD GROUP INC3804-2024-09-30625,054$903,00082,000

?

? ?  CAMBRIDGE INVESTMENT RESEARCH ADVISORS INC2015-2024-09-30554,400$801,000465,500

?

? ?  Rosalind Advisors Inc.23-2024-09-30502,828$727,000-104,969

?

? ?  ACADIAN ASSET MANAGEMENT LLC1004-2024-09-30482,595$696,000205,087

?

? ?  SHIKIAR ASSET MANAGEMENT INC53-2024-09-30235,969$342,00010,000

?

? ?  ENVESTNET ASSET MANAGEMENT INC3830-2024-09-30183,946$266,00073,892

?

? ?  PVG ASSET MANAGEMENT CORP24-2024-06-30155,675$266,00024,185

?

? ?  GEODE CAPITAL MANAGEMENT LLC3834-2024-09-30168,607$244,00037,736

?

? ?  NANTAHALA CAPITAL MANAGEMENT, LLC113-2024-09-30153,152$221,0000

?

? ?  NATIONAL ASSET MANAGEMENT, INC.1222-2024-06-30120,814$207,000-23,886

?

? ?  BLACKROCK INC.4260-2024-06-30109,957$188,00035,018

?

? ?  BlackRock Inc.4257-2024-09-30111,028$160,0000

?

? ?  CI Private Wealth LLC2238-2024-09-30100,326$145,0000

?

? ?  GSA CAPITAL PARTNERS LLP1476-2024-09-3081,774$118,000-113,505

?

? ?  RENAISSANCE TECHNOLOGIES LLC3233*New2024-09-3078,088$113,00078,088

?

? ?  ATRIA INVESTMENTS LLC1865-2024-09-3071,484$103,00026,351

?

? ?  180 WEALTH ADVISORS LLC434-2024-09-3068,300$99,0005,950

?

? ?  COMMONWEALTH EQUITY SERVICES LLC.3790-2024-09-3061,497$89,000-204

?

? ?  HB Wealth Management LLC920*New2024-09-3055,333$80,00055,333

?

? ?  Integrated Wealth Concepts LLC1610-2024-09-3046,100$67,00018,700

?

? ?  NORTHERN TRUST CORP4163-2024-09-3041,373$60,000-4,785

?

? ?  TITLEIST ASSET MANAGEMENT LLC272-2024-09-3039,000$56,000-1,080

?

? ?  RSM US WEALTH MANAGEMENT LLC1550-2024-09-3036,250$52,0000

?

? ?  CITADEL ADVISORS LLC4854-2024-09-3035,563$51,00026,268

?

? ?  Telemetry Investments L.L.C.99*New2022-12-3172,000$47,00072,000

?

? ?  PRUDENTIAL FINANCIAL INC2626-2024-09-3031,533$46,0009,800

?

? ?  WEALTH ENHANCEMENT ADVISORY SERVICES LLC2546-2024-09-3030,550$44,000-20,266

?

? ?  FMR LLC3699-2024-09-3026,467$38,0001,806

?

? ?  STATE STREET CORP3937-2024-09-3025,966$38,0000

?

? ?  GROUP ONE TRADING, L.P.1068-2024-09-3025,696$37,00014,800

?

? ?  Financial Advocates Investment Management743-2024-09-3022,039$32,0000

?

? ?  Meridian Wealth Management LLC621-2024-09-3020,500$30,000-45,000

?

? ?  SUSQUEHANNA INTERNATIONAL GROUP, LLP5109-2024-09-3019,862$29,0001,011

?

? ?  PFG Investments LLC988-2024-09-3019,291$28,0003,000

?

? ?  Cetera Investment Advisers3555-2024-09-3018,989$27,0002,223

?

? ?  MILLENNIUM MANAGEMENT LLC3828-2024-09-3017,151$25,000-48,025

?

? ?  Weaver Consulting Group220-2024-09-3017,298$25,0005,895

?

? ?  Gladstone Institutional Advisory LLC679-2024-09-3015,000$22,000-6,500

?

? ?  CITIGROUP INC4204*New2024-09-3012,917$19,00012,917

?

? ?  SeaCrest Wealth Management LLC644-2024-09-3012,000$17,0001,000

?

? ?  WELLS FARGO & CO/MN5095-2024-09-308,654$13,000221

?

? ?  MACQUARIE GROUP LTD1557-2024-09-306,666$10,0000

?

? ?  TOWER RESEARCH CAPITAL LLC4378-2024-09-303,496$5,0002,536

?

? ?  Russell Investments Group Ltd.3188-2024-09-302,080$3,0000

?

? ?  MORGAN STANLEY6750-2024-09-302,024$3,0000

?

? ?  J P MORGAN CHASE & CO5294-2024-09-30672$1,0000

?

? ?  BANK OF AMERICA CORP /DE/6146-2024-09-30909$1,00027

?

? ?  BNP PARIBAS ARBITRAGE SA3112-2024-09-30376$1,0000

?

? ?  Qube Research & Technologies Ltd2738*Closed2024-09-300$0-2

?

? ?  Axiom Investment Management LLC126*Closed2022-12-310$0-265

?

? ?  FEDERATED INVESTORS INC /PA/2031*New2024-09-30263$0263

?

? ?  NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO3351-2024-09-3033$0-40

?

? ?  Advisor Group Holdings Inc.6930-2024-09-3030$0-1,000

?

? ?  Cassaday & Co Wealth Management LLC320*Closed2024-09-300$0-20,584

?

? ?  PROEQUITIES INC.6487-2024-09-300$00

?

? ?  Keudell/Morrison Wealth Management230*Closed2024-09-300$0-13,000

?

? ?  MYDA Advisors LLC141*Closed2024-09-300$0-37,000

?

? ?  Newbridge Financial Services Group Inc.1123-2024-09-30133$00

?



  58 Records found

  1    

  Page 1 of 1

?

?

?







Free Registration Required For Full Results

      

    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us

👍️ 1
rbl100 rbl100 1 mes hace
Whatever you say.

Might even resume preferred dividends too. Ya never know.
👍️0
Paullee Paullee 1 mes hace
there is no insider buying going on
👍️0
rbl100 rbl100 1 mes hace
Insiders buying now too : )
👍️0
chumfm chumfm 1 mes hace
Yes the FDA date is Dec.28th,on or before.Both FBIO and CKPT could see a nice move into the new year.Good luck and good trading.
👍️0
rbl100 rbl100 1 mes hace
FDA approval is expected by end of month
👍️0
StocktonCA StocktonCA 1 mes hace
Houston, We have Lift-off!!!!
👍️0
StocktonCA StocktonCA 1 mes hace
Undervalued, ready to break out!
👍️0
chumfm chumfm 2 meses hace
Will break it's 52 week high of $4.43 when the FDA gives it the nod on Monday Nov.4th,2024.They will be the only bio to provide such.It will increase by the end of today and expode on Monday,with the approval.Good luck and good trading.
👍️0
rbl100 rbl100 3 meses hace
They are probably a shorter. The lowest form of humanity. These people bankrupt companies and kill jobs for others who work in these companies that get their stocks shorted. They thrive on wickedness and evil. And get joy and jollies from hurting others.
👍️0
investtemp investtemp 4 meses hace
If your book only contained all your post on I hub it would be about 500 pages
👍️0
Monksdream Monksdream 4 meses hace
FBIO 10 day hourly
👍️0
Monksdream Monksdream 5 meses hace
FBIO 10Q due AUGUST 19
👍️0
Monksdream Monksdream 5 meses hace
FBIO under $3
👍️0
Monksdream Monksdream 6 meses hace
FBIO under $2
👍️0
Monksdream Monksdream 8 meses hace
FBIO under $2
👍️0
Monksdream Monksdream 10 meses hace
FBIO under $2
👍️0
triannual triannual 11 meses hace
Buy order @ $1.40 / 1000 shares. GLTA!
👍️0
rbl100 rbl100 12 meses hace
Not exactly certain, but I am holding for the results. I almost sold some shares for some pocket money but held off. Don't want to miss any news. My luck is I sell and then news hits and it takes off. My CA is $1.29 per share. No skin off my back with the drop.
👍️0
conix conix 1 año hace
At some point, these biotechs need to prove they have promising drug candidates in clinical trials and are not just good at raising capital
👍️ 1
Sierra20 Sierra20 1 año hace
$11 million offering. Ouch.
👍️0
Sierra20 Sierra20 1 año hace
1/3 PDUFA is no longer valid.
👍️0
rabbit67 rabbit67 1 año hace
When is next fda news jan19?
👍️0
1hot toddy 1hot toddy 1 año hace
yahoo finance says $41 price in 1 year $$$$$$$$$$$
👍️0
rbl100 rbl100 1 año hace
This thing could be like Bill Bixby. You know the 1978 series whereby just before he gets extreme stress and anger. Holding for next year+++.
👍️0
rbl100 rbl100 1 año hace
Check it out now. Glad I held. Very low float. Nice gem I was tipped off about and looking forward to the FDA approvals.
👍️0
1hot toddy 1hot toddy 1 año hace
MONSTER BIG BUYS 15000 AND 14000 SHARES. $30K EACH BUY
👍️0
rbl100 rbl100 1 año hace
Shorts kept it in check. Profit takers made it drop. No volume for them to brag about. So the drop is normal business as usual. If you see a large drop AND very large abnormal volume... that is when to worry. Remember insiders bought this stock at an average of $9.00 + per share pre R/S. They know it is going into the $40's next year... Nice 20 bagger.
👍️ 1
TrendTrade2016 TrendTrade2016 1 año hace
FBIO PUSHING UP IN PRE, LETS SEE THAT 3 DOLLA
👍️0
TrendTrade2016 TrendTrade2016 1 año hace
Stick to your hobby of posting 52 week high and 52 week lows chief.
👍️0
TrendTrade2016 TrendTrade2016 1 año hace
FBIO HOLY FUC!!!
👍️0
TrendTrade2016 TrendTrade2016 1 año hace
FBIO FAB!!!
👍️0
TrendTrade2016 TrendTrade2016 1 año hace
FBIO MONSTER
👍️0
rbl100 rbl100 1 año hace
More than the float traded today. Unless I am seeing things LOL.
👍️ 1
TrendTrade2016 TrendTrade2016 1 año hace
Chief keep posting your 52 week highs and lows. Get a better hobby
👍️0
rbl100 rbl100 1 año hace
Then don't waste your time here. No one needs anyone to protect them from themselves. We have enough with gubberment. Speaking of which should be abolished.
👍️0
Monksdream Monksdream 1 año hace
It’s a wash trade event
You’re pushing the envelope
👍️0
rbl100 rbl100 1 año hace
That is fine, but this one is looking promising as time goes on. Got to be in it to win it. FDA rubber stamps approvals these days. Years ago it was a different story. They relaxed most standards, so not worried at all. late 2020 and 2021 proved it with the CLOVER schots. FDA is nothing but a paid co-conspirator to bad. So use it to your benefit.
👍️0
TrendTrade2016 TrendTrade2016 1 año hace
FBIO...NEXT STOP 2.27
👍️0
TrendTrade2016 TrendTrade2016 1 año hace
FBIO...MONSTER
👍️0

Su Consulta Reciente

Delayed Upgrade Clock